Working... Menu

A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease (Open PRIDE-HD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02494778
Recruitment Status : Terminated (This study served its purpose in providing considerable safety data. The decision to terminate the studies was not based on any new or emerging safety concern.)
First Posted : July 10, 2015
Last Update Posted : March 6, 2019
Information provided by (Responsible Party):
Prilenia Therapeutics Development Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 12, 2018
  Actual Study Completion Date : January 12, 2018